ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,509Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 2456

$986K Total Retail Price of All Prescriptions

Rank: 37 out of 2456

436 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 436 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 20,114 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,566 1,531 1 9
FUROSEMIDE 1,094 1,085 2 8
TRAZODONE HCL 923 908 3 17
DONEPEZIL HCL 695 695 4 23
LISINOPRIL 674 667 5 1
LEVOTHYROXINE SODIUM 668 651 6 4
METOPROLOL TARTRATE 556 554 7 10
MIRTAZAPINE 531 531 8 29
CITALOPRAM HBR 496 484 9 14
AMLODIPINE BESYLATE 436 436 10 5
NAMENDA 407 407 11 42
ATENOLOL 372 372 12 6
SIMVASTATIN 344 336 13 2
GABAPENTIN 317 281 14 16
SERTRALINE HCL 303 303 15 21
POTASSIUM CHLORIDE 300 299 16 33
DIVALPROEX SODIUM 290 290 17 51
SPIRONOLACTONE 280 280 18 73
QUETIAPINE FUMARATE 266 266 19 47
METOPROLOL SUCCINATE 239 231 20 13
SPIRIVA 236 236 21 43
LANTUS 219 210 22 44
OMEPRAZOLE 216 200 23 3
PREDNISONE 212 211 24 39
ADVAIR DISKUS 198 196 25 36
ISOSORBIDE MONONITRATE ER 193 193 26 48
TRAMADOL HCL 191 190 27 24
METFORMIN HCL 180 179 28 11
PAROXETINE HCL 175 175 29 56
CYMBALTA 170 159 30 65
RISPERIDONE 170 170 30 50
CARBIDOPA-LEVODOPA 165 163 32 82
OLANZAPINE 163 163 33 57
NOVOLOG 153 153 34 100
TAMSULOSIN HCL 151 145 35 32
DIGOXIN 150 150 36 49
LIDODERM 145 144 37 58
LEVETIRACETAM 134 134 38 90
HYDROCHLOROTHIAZIDE 118 118 39 7
LATANOPROST 106 106 40 156
HYDROCODONE-ACETAMINOPHEN 101 101 S3 41 20
BRIMONIDINE TARTRATE 96 96 42 249
FINASTERIDE 95 88 43 66
NYSTATIN 94 92 44 99
BUPROPION HCL SR 93 84 45 119
ALLOPURINOL 92 83 46 27
ESCITALOPRAM OXALATE 89 89 47 116
CLOPIDOGREL 89 83 47 55
DIOVAN 86 86 49 26
LOSARTAN POTASSIUM 85 84 50 18
SEROQUEL 83 83 51 102
DILTIAZEM 24HR CD 83 83 51 113
ALBUTEROL SULFATE 81 80 53 165
IPRATROPIUM-ALBUTEROL 80 79 54 85
LOVASTATIN 79 79 55 34
KLOR-CON M20 79 79 55 69
ROPINIROLE HCL 79 79 55 148
PANTOPRAZOLE SODIUM 78 78 58 37
GLIPIZIDE 77 77 59 46
TERAZOSIN HCL 76 76 60 76
VENLAFAXINE HCL ER 75 74 61 92
FAMOTIDINE 74 74 62 84
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 73 63 147
TIMOLOL MALEATE 71 71 64 231
FLUOXETINE HCL 70 70 65 45
NOVOLIN N 69 69 66 202
CLOTRIMAZOLE 65 64 67 332
RANITIDINE HCL 64 64 68 31
POLYETHYLENE GLYCOL 3350 63 59 69 64
RAMIPRIL 62 62 70 158
NYSTOP 61 61 71 125
ATORVASTATIN CALCIUM 61 58 71 12
AZITHROMYCIN 60 60 73 60
FLUTICASONE PROPIONATE 59 55 74 30
VERAPAMIL ER 58 58 75 91
TRIAMCINOLONE ACETONIDE 57 57 76 131
PLAVIX 53 51 77 79
EXELON 53 53 77 161
HYDRALAZINE HCL 52 52 79 105
OXYBUTYNIN CHLORIDE ER 50 50 80 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.